# RCT: Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses

> **NCT02092519** · PHASE4 · COMPLETED · sponsor: **Changi General Hospital** · enrollment: 40 (actual)

## Conditions studied

- Pancreatic Neoplasm
- Pancreatic Diseases

## Interventions

- **DEVICE:** Needle with sideport (NA-230H-8020)
- **DEVICE:** Needle without sideport (NA-220H-8022)

## Key facts

- **NCT ID:** NCT02092519
- **Lead sponsor:** Changi General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-07-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02092519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02092519, "RCT: Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02092519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*